FDA Warning Letter — Badrivishal Chemicals & Pharmaceuticals
The FDA took a Warning Letter action against Badrivishal Chemicals & Pharmaceuticals on March 6, 2017 (Dist. Pune, India). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Badrivishal Chemicals & Pharmaceuticals
- Date
- March 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Dist. Pune (India)